Medicus Sciences Acquisit...

NASDAQ: MSAC · Real-Time Price · USD
10.17
0.01 (0.05%)
At close: Feb 17, 2023, 8:47 PM

Company Description

Medicus Sciences Acquisition Corp. does not have significant operations.

The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally.

The company was incorporated in 2020 and is based in New York, New York.

Medicus Sciences Acquisition Corp.
Medicus Sciences Acquisition Corp. logo
Country United States
IPO Date Apr 5, 2021
Industry Shell Companies
Sector Financial Services
Employees n/a
CEO Jacob Jay Gottlieb

Contact Details

Address:
152 West 57th Street
New York City, New York
United States
Website https://www.medicusspac.com

Stock Details

Ticker Symbol MSAC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001836517
CUSIP Number G5960S108
ISIN Number KYG5960S1084
Employer ID 00-0000000
SIC Code 6770

Key Executives

Name Position
Dr. Michael Bernard Castor M.D. Chief Executive Officer & Director
Dr. Judah Zvi Drillick CPA Chief Financial Officer
Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D. Executive Chairman
Dr. Neil Puri M.B.A., M.D. Chief Bus. Officer

Latest SEC Filings

Date Type Title
Feb 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Feb 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Feb 27, 2023 15-12G Filing
Feb 17, 2023 25-NSE Filing
Feb 14, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Feb 14, 2023 SC 13G Statement of acquisition of beneficial ownership b...
Feb 14, 2023 SC 13G Statement of acquisition of beneficial ownership b...
Feb 13, 2023 8-K Current Report
Feb 10, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jan 24, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial own...